Nonyx Leadership Target insulated discussions with NONYX product line, Xenna's flagship fungal nail clarifying gel, emphasizing dermatologist-tested credentials and US-made manufacturing to drive retail and clinic partnerships.

Retail Footprint Capitalize on established national retail presence and distributor networks (Cardinal Health, AmerisourceBergen, McKesson) to propose expanded shelf space, promotions, and cross-merchandising in foot care aisles and diabetic-friendly foot health segments.

Small Brand Scale Leverage the lean organization to offer flexible partnerships, volume-based incentives, and quick OTD (on-time delivery) for private-label or co-branded opportunities given revenue under one million and a CPG-ready manufacturing base.

Healthcare Alignment Highlight compatibility with diabetic foot care needs and FSA/HSA eligibility to target pharmacy chains, clinics, and insurance-aligned wellness programs seeking non-prescription fungal nail solutions.

Growth Readiness Position Xenna as a scalable partner for channel expansion, e-commerce acceleration (Amazon and online retailers), and pharmacy mail-order programs, backed by US sourcing, guaranteed money-back policy, and ongoing product innovation.